Ebola virus disease
Open accessThe DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Abstract
Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus (EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission, followed by human-to-human transmission via direct contact or contact with infected bodily fluids or contaminated fomites. EVD has a high case–fatality rate; it is characterized by fever, gastrointestinal signs and multiple organ dysfunction syndrome. Diagnosis requires a combination of case definition and laboratory tests, typically real-time reverse transcription PCR to detect viral RNA or rapid diagnostic tests based on immunoassays to detect EBOV antigens. Recent advances in medical countermeasure research resulted in the recent approval of an EBOV-targeted vaccine by European and US regulatory agencies. The results of a randomized clinical trial of investigational therapeutics for EVD demonstrated survival benefits from two monoclonal antibody products targeting the EBOV membrane glycoprotein. New observations emerging from the unprecedented 2013–2016 Western African EVD outbreak (the largest in history) and the ongoing EVD outbreak in the Democratic Republic of the Congo have substantially improved the understanding of EVD and viral persistence in survivors of EVD, resulting in new strategies toward prevention of infection and optimization of clinical management, acute illness outcomes and attendance to the clinical care needs of patients. Ebola virus disease (EVD) is caused by the filovirus Ebola virus (EBOV). Although the natural host of EBOV is undefined, a single zoonotic transmission is the probable start of most EVD outbreaks. EVD is characterized by gastrointestinal manifestations and multiple organ dysfunction syndrome and has a high case–fatality rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–209 of 209
Fluid resuscitation in Ebola Virus Disease: A comparison of peripheral and central venous accesses
Cotté, J., Cordier, P., Bordes, J., Janvier, F., Esnault, P., Kaiser, É., & Meaudre, É. (2015) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2015.06.010 · Cited by 17
Ebola Infection in Pregnancy: A Global Perspective and Lessons Learned
Haddad, L. B., Horton, J. P., Ribner, B. S., & Jamieson, D. J. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000332 · Cited by 17
Ippolito, G., Di, A., & Capobianchi, M. R. (2015) · Infectious Disease Reports · doi:10.4081/idr.2015.5957 · Cited by 13
A Modified Case Definition to Facilitate Essential Hospital Care During Ebola Outbreaks
Huizenga, E., van der Ende, J., Zwinkels, N., Jimissa, A. S., van der Ende-Bouwman, C., van Rooijen, R., Kargbo, B., Agnandji, S. T., Hänscheid, T., Goorhuis, A., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy798 · Cited by 13
Sams, K., Desclaux, A., & Sow, S. (2019) · Anthropology and Medicine · doi:10.1080/13648470.2019.1615749 · Cited by 11
Principles and Practices of Establishing a Hospital-Based Ebola Treatment Unit
Kiiza, P., Adhikari, N. K. J., Mullin, S. I., Teo, K., & Fowler, R. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2019.06.011 · Cited by 11
Kangbai, J. B., Heumann, C., Höelscher, M., Sahr, F., & Froeschl, G. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3727-7 · Cited by 10
Sur l’origine d’Ebola : discours biomédical versus interprétations populaires à Macenta en Guinée
Thys, S., & Boelaert, M. (2017) · Santé Publique · doi:10.3917/spub.174.0497 · Cited by 9
Trial of ZMapp for Ebola Virus Infection.
Davey, R. T., Nordwall, J., & Proschan, M. A. (2017) · PubMed · doi:10.1056/nejmc1614625 · Cited by 8
Cited by
Looking beyond COVID-19 vaccine phase 3 trials
Kim, J. H., Marks, F., & Clemens, J. D. (2021) · Nature Medicine · doi:10.1038/s41591-021-01230-y · Cited by 585
Geldsetzer, P. (2020) · Journal of Medical Internet Research · doi:10.2196/18790 · Cited by 504
Vaccine development for emerging infectious diseases
Excler, J.-L., Saville, M., Berkley, S., & Kim, J. H. (2021) · Nature Medicine · doi:10.1038/s41591-021-01301-0 · Cited by 410
Nanoparticle Size Effects in Biomedical Applications
Dolai, J., Mandal, K., & Jana, N. R. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c00987 · Cited by 358
Virginia Anikwe, C., Friday Nweke, H., Chukwu Ikegwu, A., Adolphus Egwuonwu, C., Uchenna Onu, F., Rita Alo, U., & Wah Teh, Y. (2022) · Expert Systems with Applications · doi:10.1016/j.eswa.2022.117362 · Cited by 233
Metadata
- Authors
- Jacob, S. T., Crozier, I., Fischer, W. A., Hewlett, A., Kraft, C. S., Vega, M.-A. D. L., Soka, M. J., Wahl, V., Griffiths, A., Bollinger, L., & Kuhn, J. H.
- Venue
- Nature Reviews Disease Primers
- Published
- 2020-02-20
- Volume
- 6
- Issue
- 1
- Pages
- 13-13
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211119126
- Cited by
- 664
- References
- 209
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.